PREPOPIK (citric acid; magnesium oxide; sodium picosulfate) by Ferring Pharmaceuticals is metabolite: bis-(p-hydroxy-phenyl)-pyridyl-2-methane, bhpm, which acts directly on the colonic mucosa to stimulate colonic peristalsis. First approved in 2012.
Drug data last refreshed 15h ago · AI intelligence enriched 2w ago
PREPOPIK is an oral bowel-cleansing solution combining sodium picosulfate (a stimulant laxative), magnesium oxide, and citric acid for pre-procedure gastrointestinal preparation. The sodium picosulfate metabolite BHPM stimulates colonic peristalsis while magnesium citrate (generated in-situ) acts as an osmotic agent to retain water in the GI tract. It is indicated for patients requiring bowel preparation prior to colonoscopy or other GI procedures.
Product is approaching loss of exclusivity with 2.2 years remaining; expect team consolidation and shift toward brand defense and lifecycle management strategies.
metabolite: bis-(p-hydroxy-phenyl)-pyridyl-2-methane, BHPM, which acts directly on the colonic mucosa to stimulate colonic peristalsis. Magnesium oxide and citric acid react to create magnesium citrate in solution, which is an osmotic agent that causes water to be retained within the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy
Worked on PREPOPIK at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
LOE in ~3 years — strategic planning for patent cliff underway
PREPOPIK offers limited career growth opportunities due to its approaching loss of exclusivity and mature market position. Roles on this product are best suited for professionals with expertise in competitive defense, cost management, and transition planning rather than launch or growth-phase expansion.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo